Abstract
Human mobility plays a crucial role in determining how fast and where infectious diseases can spread. This study aims to investigate visit to which category of places among grocery, retail, parks, workplaces, residential, and transit stations is more associated with the incidence of COVID-19 in India. A longitudinal analysis of generalized estimating equation (GEE) with a Poisson log-linear model is employed to analyze the daily mobility rate and reported new cases of COVID-19 between March 14 and September 11, 2020. This study finds that mobility to places of grocery (food and vegetable markets, drug stores etc.) and retail (restaurants, cafes, shopping centres etc.) is significantly associated (at p<0.01) with the incidence of COVID-19. In contrast, visits to parks, transit stations and mobility within residential neighbourhoods are not statistically significant (p>0.05) in changing COVID-19 cases over time. These findings highlight that instead of blanket lockdown restrictions, authorities should adopt a place-based approach focusing on vulnerable hotspot locations to contain the COVID-19 and any future infectious disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB/oversight body approval was not necessary as there was no clinical trial and survey conducted. The anonymized data was compiled from an open-source.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
We have made the research data available through the Mendeley Data at http://dx.doi.org/10.17632/wpywf5ny6j.1